Quantum Biopharma (QNTM) Gains from Investment Securities (2019 - 2025)
Quantum Biopharma (QNTM) reported Gains from Investment Securities of -$12.1 million for Q4 2025, down 38760.91% on a YoY basis from N/an in Q4 2024, and down 1065.94% sequentially from $1.3 million in Q3 2025.
Quantum Biopharma (QNTM) Gains from Investment Securities (2019 - 2025) Analysis & Trends
Quantum Biopharma (QNTM) has 7 years of Gains from Investment Securities data on file, last reported at -$12.1 million in Q4 2025.
- For the quarter ending Q4 2025, Gains from Investment Securities fell 38760.91% year-over-year to -$12.1 million; the trailing twelve-month figure through Dec 2025 stood at -$175194.0 (changed N/A YoY), and the FY2025 full-year result was -$175194.0, changed N/A from the prior year.
- Gains from Investment Securities declined to -$12.1 million in Q4 2025, from $1.3 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $7.5 million in Q2 2025 to a low of -$12.1 million in Q4 2025.
- A 5-year average of $45875.8 and a median of $19647.5 in 2023 frame the typical range for Gains from Investment Securities.
- Peak annual rise in Gains from Investment Securities reached 1690813.51% in 2025, while the deepest fall reached 38760.91% in 2025.
- Tracing QNTM's Gains from Investment Securities over 5 years: stood at $839376.0 in 2021, then slumped by 117.0% to -$142696.0 in 2022, then surged by 179.34% to $113211.0 in 2023, then plunged by 72.39% to $31263.0 in 2024, then tumbled by 38760.91% to -$12.1 million in 2025.
- Business Quant data shows QNTM's Gains from Investment Securities at -$12.1 million in Q4 2025, $1.3 million in Q3 2025, and $7.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Quantum Biopharma | 13.00 Bn | 13.00 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -12.09 Mn |
| Dec 31, 2025 | -12.09 Mn |
| Sep 30, 2025 | 1.25 Mn |
| Sep 30, 2025 | 1.25 Mn |
| Jun 30, 2025 | 7.55 Mn |
| Jun 30, 2025 | 7.55 Mn |
| Mar 31, 2025 | 3.11 Mn |
| Mar 31, 2025 | 3.11 Mn |
| Dec 31, 2024 | 31,263.00 |
| Dec 31, 2024 | 31,263.00 |
| Sep 30, 2024 | 74.00 |
| Sep 30, 2024 | 74.00 |
| Jun 30, 2024 | -8,040.00 |
| Jun 30, 2024 | -8,040.00 |
| Mar 31, 2024 | -23,297.00 |
| Mar 31, 2024 | -23,297.00 |
| Dec 31, 2023 | 113,211.00 |
| Dec 31, 2023 | 113,211.00 |
| Sep 30, 2023 | 8,032.00 |
| Sep 30, 2023 | 8,032.00 |